Complicated urinary tract infections are infections in the setting of
structural or functional abnormalities of the genitourinary tract. The
y encompass a wide variety of clinical syndromes and anticipated outco
mes. The infecting microorganisms isolated are more varied and demonst
rate a higher prevalence of antimicrobial resistance in complicated co
mpared to uncomplicated urinary tract infections. The usual duration o
f therapy is 7 to 14 days, although comparative trials to define optim
al treatment duration are lacking. Long term success of antimicrobial
treatment is dependent upon whether or not the underlying genitourinar
y abnormality can be corrected. Treatment of complicated urinary tract
infections will usually be successful and may be permanent if the und
erlying abnormality can be corrected. If the underlying abnormality ca
nnot be corrected, failure rates of 50% at 4 to 6 weeks following ther
apy are expected. Antimicrobial agents are similar to those used to tr
eat uncomplicated urinary tract infection. Certain agents, such as nit
rofurantoin, should be avoided for individuals with renal failure. No
specific agent or class of agents has consistently demonstrated greate
r therapeutic efficacy where the infecting organism is susceptible to
the given agent.